Ultime notizie per Aspira Womens Health (OTC:AWHL) Azioni

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

ASPIRA WOMEN'S HEALTH INC by Aspira Women's Health Inc.

Aspira Womens Health Inc

<a href="https://www.youtube.com/watch?v=E9KW7xNK02E">https://www.youtube.com/watch?v=E9KW7xNK02E</a>

News

General

White House Press Secretary Karoline Leavitt Says President Trump Will Go To Nato Summit

<a href="https://www.reuters.com/business/us-pushes-countries-best-offers-by-wednesday-tariff-deadline-looms-2025-06-02/">https://www.reuters.com/business/us-pushes-countries-best-offers-by-wednesday-tariff-deadline-looms-2025-06-02/</a>
&nbsp;

Macro Economic Events

Global

Economics

Reported June 2, 2025: 'US Pushes Countries For Best Offers By Wednesday As Tariff Deadline Looms' - Reuters Exclusive

<a href="https://www.chicagofed.org/publications/speeches/2025/june-3-corridor-business-journal" title="https://www.chicagofed.org/publications/speeches/2025/june-3-corridor-business-journal">https://www.chicagofed.org/publications/speeches/2025/june-3-corridor-business-journal</a>

Federal Reserve

Fed's Goolsbee Says Escalating Unbounded Trade War Could Spiral Up Inflation Rate

In a quarter where most big U.S. cannabis companies flatlined, one actually grew: Green Thumb Industries Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTCQX">GTBIF</a>).
The Chicago-based company reported $280 million in revenue for the quarter, a 1% increase over Q1 2024. According to a new <a href="https://zuanic.worldflowconnect.net/opendirect/c9997154-e6c0-4ee2-8a8b-95f80a46610c/250602%20Green%20Thumb.pdf?token=7fd498e2-a6df-44ea-98bc-a73510f4470c&amp;extension=.pdf">report</a> from Zuanic &amp; Associates, no other operator in its peer group achieved positive growth during the same period. That makes GTI a notable outlier in a sector where revenue declines and flatlining were the norm.
<h3 class="wp-block-heading">Brand Strength And Sales Strategy</h3>
A key factor behind Green Thumb's performance is its strong portfolio of in-house brands, which account for roughly 90% of the company's retail sales. Wholesale also played a significant role, contributing 29% of total revenue, an indicator of manufacturing scale and brand traction beyond GTI's own stores.
<h3 class="wp-block-heading">Profitability And Cash Flow</h3>
Green Thumb reported an adjusted EBITDA margin of 30.5% and a gross margin of 51.3% in Q1. The company's SG&amp;A expenses totaled 70% of gross profit, reflecting tight cost control.
Operating cash flow came in at $43 million, the highest among the Tier 1 operators covered in the report. Zuanic highlighted GTI's cash conversion rate (51% of EBITDA) as a key sign of financial health.
<h3 class="wp-block-heading">Conservative Tax Positioning</h3>
While some industry players are adjusting their 280E tax provisions in anticipation of possible reform, Green Thumb continues to account for the full liability. Zuanic frames this as a conservative approach that may prove prudent if legislative changes are delayed or fail to materialize.
<h3 class="wp-block-heading">Strong Balance Sheet</h3>
Green Thumb also leads in balance sheet discipline. Net debt to EBITDA is just 0.1x. Including deferred tax liabilities, the ratio rises to only 0.2x. The company reported $210 million in cash as of quarter-end.
<h3 class="wp-block-heading">Analyst Take</h3>
Zuanic reiterated an Overweight rating on GTI, citing growth, brand strength, operational efficiency and a conservative financial strategy as key differentiators.
Read the full report on Zuanic&#8217;s <a href="https://zuanicgroup.com/">website</a>.
Photo: Shutterstock

Reiteration

GTBIF

This US Cannabis Company Did What None Of Its Peers Could In Q1: Grow

Fed's Goolsbee Says Not Surprising To See Fluctuations In Value Of Dollar, Given The Trade Policy And Uncertainty

Fed's Goolsbee Says Concern That Dollar Will Stop Being World Reserve Currency Looks Overstated

<a href="https://www.youtube.com/watch?v=6pbToUoMdaw" title="https://www.youtube.com/watch?v=6pbToUoMdaw">https://www.youtube.com/watch?v=6pbToUoMdaw</a>

Fed's Cook Says Sees Challenges To Fed Mandates From Tariffs But Need To See How It Plays Out

Politics

JBLU

ULCC

Reuters Cites Letter Saying Major Airlines Warn New Trump Tariffs On Imported Planes, Parts Could "Dismantle" Recovering Supply Chain, Put Aviation Safety At Risk

Algonquin Power &amp; Utilities Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AQN#NYSE">AQN</a>) shares are trading higher on Tuesday after the company provided adjusted EPS <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b45741503/algonquin-power-utilities-corp-announces-financial-outlook-for-2025-through-2027" rel="noreferrer noopener">guidance from 2025 through 2027</a>.
The company sees adjusted net EPS of 30 cents to 32 cents in 2025, 35 cents to 37 cents in 2026,<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener"> and 42 cents to 46 cents in 2027</a>.
The company expects operating expenses as a percentage of revenue to improve by 5%–7% by year-end 2027 and earned ROE to rise by ~300 bps to around 8.5% by 2027.
Algonquin Power projects utility capital expenditures of around $2.5 billion for 2025-2027.
Rod West, CEO of AQN said, &#8220;The plan for the future is shaped around intertwining operational excellence and stakeholder engagement in the DNA of the Company to achieve better outcomes for all stakeholders.&#8221;
Last month, the company reported a first-quarter adjusted EPS of $0.14, beating the consensus of 10 cents, and sales of $692.40 million, which exceeded the <a href="https://www.benzinga.com/pressreleases/25/05/b45313119/algonquin-power-utilities-corp-announces-2025-first-quarter-financial-results-plans-to-host-invest" target="_blank" rel="noreferrer noopener">street view of $651.00 million</a>.
Investors can gain exposure to the stock via&nbsp;iShares U.S. Infrastructure ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IFRA#BATS">IFRA</a>).
AQN Price Action: Algonquin shares are up 11.84% at $6 at publication on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/03/44197558/whats-moving-markets-friday" target="_blank" rel="noreferrer noopener">Nasdaq Falls Into Correction As Tariffs Roil Wall Street: What&#8217;s Moving Markets Friday?</a></li>
</ul>
Photo: Piotr Swat via Shutterstock

Guidance

IFRA

Why Algonquin Power Stock Is Surging On Tuesday

<a href="https://www.cfr.org/event/c-peter-mccolough-series-international-economics-lisa-d-cook?utm_medium=social_owned&amp;utm_source=tw" title="https://www.cfr.org/event/c-peter-mccolough-series-international-economics-lisa-d-cook?utm_medium=social_owned&amp;utm_source=tw">https://www.cfr.org/event/c-peter-mccolough-series-international-economics-lisa-d-cook?utm_medium=social_owned&amp;utm_source=tw</a>

Fed's Cook Says I See Higher Inflation And Slower Activity Due To Tariffs; Tariffs Could Bring Stagflation Like Environment

Fed's Goolsbee Says All Indicators Point To Stable, Full Employment

Discount retailer Dollar Tree Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) could highlight changing consumer spending habits and the impact of tariffs on consumers when the company reports first-quarter financial results before <a href="https://www.benzinga.com/earnings">market open Wednesday.</a>
Here are the analyst estimates, what they&#8217;re saying ahead of the report and key items to watch.
Earnings Estimates: Analysts expect Dollar Tree to report first-quarter sales of $4.54 billion, down from $7.63 billion in last year's first quarter, according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0603">from Benzinga Pro.</a>
The company has beaten analyst estimates for sales in two straight quarters and seven of the last 10 quarters overall. Lower sales figures are due to the exclusion of the Family Dollar business, which is being sold off.
Analysts expect the company to report earnings per share of $1.20 in the first quarter, down from $1.43 in the same period last year.
The company has beaten analyst estimates for earnings per share in two straight quarters and six of the last 10 quarters overall.
Guidance<a href="https://www.benzinga.com/news/earnings/25/03/44491397/dollar-tree-q4-earnings-surpass-estimates-unloads-family-dollar-for-1b"> from the company </a>calls for first-quarter adjusted EPS to be in a range of $1.10 to $1.25.
Read Also:<a href="https://www.benzinga.com/trading-ideas/25/04/44879155/dltr-stock-insider-buys-unusual-options-rally"> Options Corner: Why The Big Bettors Say Dollar Tree Has More Value To Unlock</a>
What Analysts Are Saying: Goldman Sachs analyst Kate McShane gave Dollar Tree <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44797563/goldman-sachs-sees-upside-in-retail-giants-dollar-tree-home-depot-best-buy-and-target-despite-tariff-margin-pressures">a Buy rating</a> and $86 price target ahead of the earnings report after positive commentary from management on the impact of tariffs.
McShane said Dollar Tree management said tariffs typically take three to four months, or more than a quarter, to impact inventory, which could provide a buffer before tariffs impact financial results.
She added that Dollar Tree's pricing and cost strategies could help offset tariff impact and maintain the company's value offerings.
McShane said Dollar Tree showed strength in the fourth quarter and that could continue into the first quarter results. She said the company's sale of Family Dollar could improve free cash flow.
Citi Research analyst Paul Lejuez<a href="https://www.benzinga.com/25/04/44677660/the-new-bull-case-for-dollar-tree-raise-prices-boost-margins-blame-tariffs"> upgraded Dollar Tree</a> stock ahead of the earnings report, raising it from a Neutral rating to a Buy rating and a $103 price target.
The analyst said Dollar Tree could be one of the "silent beneficiaries' of the tariff trade.
Lejuez said higher tariffs could enable Dollar Tree to raise its prices from its $1.25 standard price to $1.50 or even $1.75, which would boost margins. While it would help offset some higher costs, he said, it would allow the company to raise prices without as much blowback as doing this in a non-tariff impacted time.
Here are other recent <a href="https://www.benzinga.com/quote/DLTR/analyst-ratings">analyst ratings on Dollar Tree</a> and their price targets:
<ul class="wp-block-list">
<li>Wells Fargo: Maintained Overweight rating, raised price target from $90 to $105</li>
<li>Truist: Maintained Buy rating, raised price target from $89 to $100</li>
<li>UBS: Maintained Buy rating, raised price target from $95 to $108</li>
<li>Telsey: Maintained Market Perform rating, raised price target from $82 to $95</li>
</ul>
Key Items to Watch: Dollar Tree's financial results come a day after rival Dollar General Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) reported quarterly results and guidance.
Dollar General<a href="https://www.benzinga.com/markets/earnings/25/06/45746307/dollar-general-boosts-annual-outlook-despite-ongoing-tariff-uncertainty"> beat analyst estimates </a>for sales and earnings per share and saw strength in same-store sales during the quarter.
Perhaps more importantly, Dollar General's guidance was higher than before, with the company cautious on tariffs but showing updated expectations after the first-quarter outperformance. The company raised its full-year sales growth range from 3.4% to 4.4% to a new range of 3.7% to 4.7%. The company also raised its full-year earnings per share range from $5.10 to $5.80 to a new range of $5.20 to $5.80.
A strong quarter for Dollar General could be good news for Dollar Tree, assuming it did not lose market share and that discount retailers took share from big-box retailers.
A Placer.ai <a href="https://www.placer.ai/anchor/articles/dollar-stores-stability-in-the-new-year">report </a>showed Dollar General&#8217;s visitor growth of 1.9% in the first quarter, compared to Dollar Tree&#8217;s +4.8 %.
Dollar Tree's growth in each of the first three quarters of the year outperformed Dollar General for visitor growth in the Placer.ai report.
For the month of April, the report showed Dollar General visitors up 6.5% year-over-year, compared to Dollar Tree, which saw a 21.2% increase, a number that could factor into Dollar Tree&#8217;s guidance.
Another key item to watch is Dollar Tree's sale of the Family Dollar business for $1 billion and how it will impact the company's future financials.
"In the fourth quarter, our team was focused on successfully closing out the year, bringing the strategic review to a favorable conclusion, and setting Dollar Tree on a path to realize its full potential to create long-term value for our associates, customers, and shareholders,"&nbsp;said CEO&nbsp;Mike Creedon.
The company provided updated full-year guidance based on the sale of Dollar Tree with sales estimates set at a range of $18.5 billion and $19.1 billion and earnings per share of $5.00 to $5.50.
Analysts and investors will be closely watching to see if guidance has changed going forward.
Tariffs will be another key topic that analysts and investors are watching as Dollar Tree was one of the first retailers to <a href="https://www.benzinga.com/news/global/24/12/42402629/trump-to-change-dollar-stores-for-good-dollar-tree-exec-says-prepared-to-act">speak out about</a> potential higher prices for consumers as a result.
The company also said at the time that it could change product specs and pack sizes and stop selling unprofitable items to offset tariffs.
Dollar General's earnings report showed strength and a potential lower than expected impact from tariffs. Dollar Tree may highlight how it is getting around tariffs and commentary that could impress investors and analysts.
DLTR Price Action: Dollar Tree stock is up 3.5% to $94.41 on Tuesday versus a 52-week trading range of $60.49 to $121.96. Dollar Tree stock is up 23.4% year-to-date in 2025, while shares are down 22% over the last year.
For comparison, Dollar General stock was up 12.5% to $109.35 on Tuesday, following the company's financial results. Dollar General stock is up 44.6% year-to-date in 2025, but shares are down 22% over the last year.
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent060325">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
Photo: Shutterstock

Previews

Retail Sales

DLTR

Dollar Tree Q1 Earnings Preview: Can The Discount Retailer Beat And Raise Like Peer Dollar General?

WIIM

Novo Nordisk shares are trading lower following a report suggesting that a study found that Ozempic and other weight loss drugs may raise the risk of kidney cancer.

<a href="https://www.benzinga.com/topic/artificial-intelligence">Artificial intelligence</a> continues to reshape the venture capital landscape, commanding premium valuations and significant capital in Q1 2025, according to the latest Venture Beacon report from J.P. Morgan's Aumni and Fenwick.
The report, analyzing U.S. venture deals from Series Seed to Series D+, highlights AI's outsized influence, with AI-focused startups securing 30% of early-stage deals and 60% of late-stage capital.
"Artificial Intelligence (AI) continues to be a bright spot for the market in Q1 2025," stated Sebastian Quintero, Executive Director and Head of Applied Research &amp; AI at Aumni. 
AI-driven companies at Series A raised more capital and achieved valuations 12% to over 150% higher than non-AI counterparts across industries like healthcare, information technology, and finance. 
The report notes that AI deals have grown from less than 15% of Seed and Series A rounds in 2021 to 30% in Q1 2025.
Despite AI's dominance, the broader venture capital market faced a mild downturn, with deal sizes dropping 7.5% to 31% quarter-over-quarter and valuations declining 13% to 37% across most stages. 
Series A and Series D+ were exceptions, with valuations rising 6.2% and 30%, respectively. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45751163/ripples-stablecoin-rlusd-gets-regulatory-nod-in-dubai">Ripple&#8217;s Stablecoin RLUSD Gets Regulatory Nod In Dubai</a>
Mega deals ($100M+) remained elevated but accounted for only 4.3% of total rounds, down from a 2021 peak of 9.8%. 
These mega deals, increasingly AI-driven, raised seven times more capital and commanded 8.8 times higher valuations than conventional rounds.
The report also details shifts in deal mechanics and governance. Extension rounds rose to 28.1% from 22.5% in Q4 2024, and follow-on investments increased to 24.4%, reflecting a focus on supporting existing portfolios. 
The median time between rounds shortened to 21 months, indicating faster fundraising cycles. Board sizes at Series C+ decreased to six members from seven, suggesting streamlined governance, while founders retained stronger ownership due to lower dilution.
Investor protections strengthened, with liquidation preference multiples above 1x rising to 4.7% from 3.5% in 2024, and pay-to-play provisions gaining traction in Series B and C rounds. 
Convertible notes and SAFEs showed mixed trends, with valuation caps dropping significantly for deals over $5M and interest rates on convertible notes rising 200–300 basis points despite a declining federal funds rate.
"The first quarter of 2025 has been defined by recalibration, with strategic adjustments taking center stage," the report's foreword by Fenwick partners states. 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45749340/strategy-launches-strd-preferred-stock-offering-10-yield">Strategy Launches STRD Preferred Stock Offering 10% Yield</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

AI Dominated Venture Capital In Q1 2025, Says JP Morgan Report

Raymond James analyst Bobby Zolper initiates coverage on Badger Meter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMI#NYSE">BMI</a>) with a Market Perform rating.

Initiation

Analyst Ratings

Raymond James Initiates Coverage On Badger Meter with Market Perform Rating

<h3>Gainers</h3>
<ul>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) stock rose 50.3% to $5.59 during Tuesday's regular session. The company's market cap stands at $132.4 million. </li>
<li>YSX Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YSXT#NASDAQ">YSXT</a>) shares moved upwards by 29.13% to $8.2. The company's market cap stands at $192.1 million. </li>
<li>Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) shares moved upwards by 28.37% to $3.33. The company's market cap stands at $146.6 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock moved upwards by 18.83% to $65.8. The company's market cap stands at $45.9 million. </li>
<li>Pitanium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTNM#NASDAQ">PTNM</a>) stock increased by 16.79% to $4.73. The company's market cap stands at $107.6 million. </li>
<li>Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) shares rose 15.66% to $31.24. The market value of their outstanding shares is at $258.5 million. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Raytech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAY#NASDAQ">RAY</a>) shares fell 34.3% to $1.9 during Tuesday's regular session. The company's market cap stands at $33.4 million. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGA#NASDAQ">QVCGA</a>) shares declined by 15.82% to $2.98. The market value of their outstanding shares is at $24.0 million. </li>
<li>Yoshiharu Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YOSH#NASDAQ">YOSH</a>) shares declined by 14.81% to $13.48. The company's market cap stands at $23.7 million. </li>
<li>Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) shares declined by 13.86% to $2.3. The company's market cap stands at $7.3 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares declined by 10.28% to $1.31. The company's market cap stands at $39.4 million. </li>
<li>Ruanyun Edai Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYET#NASDAQ">RYET</a>) shares decreased by 9.07% to $8.73. The company's market cap stands at $294.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGAE

CTRN

KIDZ

PTNM

QVCGA

RYET

SBET

STRR

TLYS

YOSH

YSXT

12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<a href="https://info.westinghousenuclear.com/news/westinghouse-evinci-test-reactor-first-to-receive-approval-for-preliminary-safety-design-report" title="https://info.westinghousenuclear.com/news/westinghouse-evinci-test-reactor-first-to-receive-approval-for-preliminary-safety-design-report">https://info.westinghousenuclear.com/news/westinghouse-evinci-test-reactor-first-to-receive-approval-for-preliminary-safety-design-report</a>

'Westinghouse Electric Company Has Received Approval For Its eVinci Microreactor's Preliminary Safety Design Report From The U.S. Department Of Energy' - Westinghouse

<h3>Gainers</h3>
<ul>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock increased by 112.2% to $3.65 during Tuesday's regular session. The market value of their outstanding shares is at $2.7 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock rose 53.82% to $6.63. The company's market cap stands at $4.8 million. </li>
<li>Biomea Fusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMEA#NASDAQ">BMEA</a>) shares rose 52.58% to $2.37. The company's market cap stands at $85.7 million. </li>
<li>Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) stock moved upwards by 39.43% to $1.98. The market value of their outstanding shares is at $11.0 million. </li>
<li>I-MAB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMAB#NASDAQ">IMAB</a>) shares moved upwards by 38.28% to $1.77. The market value of their outstanding shares is at $143.1 million. </li>
<li>Perspective Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CATX#AMEX">CATX</a>) stock moved upwards by 33.47% to $3.19. The company's market cap stands at $236.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Ernexa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERNA#NASDAQ">ERNA</a>) shares fell 17.8% to $0.18 during Tuesday's regular session. The company's market cap stands at $11.2 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 15.87% to $0.5. The company's market cap stands at $9.1 million. </li>
<li>Kairos Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KAPA#AMEX">KAPA</a>) shares fell 15.83% to $0.5. The company's market cap stands at $8.3 million. </li>
<li>Zhengye Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZYBT#NASDAQ">ZYBT</a>) stock declined by 14.52% to $7.83. The company's market cap stands at $371.0 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) shares fell 12.86% to $4.27. The company's market cap stands at $38.3 million. </li>
<li>Akoya Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKYA#NASDAQ">AKYA</a>) stock decreased by 12.0% to $1.1. The company's market cap stands at $54.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKYA

BMEA

CATX

CLNN

ERNA

IMAB

INTS

KAPA

NIVF

RSLS

TRAW

ZYBT

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Complete Solaria (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares moved upwards by 22.7% to $1.86 during Tuesday's regular session. The market value of their outstanding shares is at $149.7 million. </li>
<li>New Century Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCEW#NASDAQ">NCEW</a>) stock increased by 20.95% to $1.27. The market value of their outstanding shares is at $27.3 million. </li>
<li>JVSPAC Acquisition Corp. - Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSAR#NASDAQ">JVSAR</a>) shares rose 18.15% to $0.52. </li>
<li>American Rebel Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AREB#NASDAQ">AREB</a>) stock moved upwards by 16.37% to $1.71. The market value of their outstanding shares is at $11.1 million. </li>
<li>Sunrun (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NASDAQ">RUN</a>) shares increased by 14.91% to $8.21. The company's market cap stands at $1.8 billion. </li>
<li>NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) shares rose 14.85% to $2.55. The company's market cap stands at $198.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) stock decreased by 57.5% to $1.72 during Tuesday's regular session. The company's market cap stands at $57.9 million. </li>
<li>Singularity Future Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGLY#NASDAQ">SGLY</a>) shares fell 12.49% to $0.87. The company's market cap stands at $3.6 million. </li>
<li>Nuburu (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BURU#AMEX">BURU</a>) stock declined by 12.22% to $0.31. The market value of their outstanding shares is at $16.4 million. </li>
<li>ADS-TEC Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) shares decreased by 11.19% to $9.51. The company's market cap stands at $521.6 million. </li>
<li>Nuvve Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) shares decreased by 10.01% to $1.34. The market value of their outstanding shares is at $4.9 million. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares declined by 9.19% to $3.36. The market value of their outstanding shares is at $6.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADSE

AREB

BGLC

BURU

HCAI

JVSAR

NCEW

NPWR

NVVE

SGLY

SPWR

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) stock rose 33.2% to $1.47 during Tuesday's regular session. The company's market cap stands at $172.9 million. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) stock increased by 30.11% to $35.0. The market value of their outstanding shares is at $576.1 million. </li>
<li>Global Engine Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLE#NASDAQ">GLE</a>) stock rose 23.54% to $2.75. The market value of their outstanding shares is at $50.4 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) shares increased by 22.08% to $0.84. The company's market cap stands at $22.9 million. </li>
<li>Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) shares rose 18.33% to $74.14. The market value of their outstanding shares is at $12.3 billion. The company's, Q4 earnings came out yesterday. </li>
<li>CoreWeave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) shares moved upwards by 18.27% to $142.16. The market value of their outstanding shares is at $68.2 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares fell 16.5% to $14.57 during Tuesday's regular session. The market value of their outstanding shares is at $5.1 billion. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares decreased by 13.6% to $0.42. The company's market cap stands at $17.5 million. </li>
<li>Sagtec Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAGT#NASDAQ">SAGT</a>) stock fell 13.11% to $2.52. The market value of their outstanding shares is at $31.6 million. </li>
<li>Diginex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) shares decreased by 11.22% to $40.55. The market value of their outstanding shares is at $932.3 million. </li>
<li>Iveda Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVDA#NASDAQ">IVDA</a>) stock decreased by 7.15% to $2.34. The market value of their outstanding shares is at $6.5 million. </li>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) shares declined by 6.67% to $1.26. The company's market cap stands at $12.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATGL

BNAI

CRDO

CRWV

DGNX

IVDA

MLGO

PCLA

PONY

REKR

SAGT

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Biotech

Press Releases

Aspira Reaches Another ARPA-H Milestone,  Eligible to Receive Additional $1.5 Million in Second Quarter

Aspira Successfully Completes Application to the OTCQB

Earnings

Aspira Announces First Quarter 2025 Financial Results and Provides Business Update

AWHL

Aspira Womens Health

Comments

Aspira Womens Health

Notizie

Ultime notizie per Aspira Womens Health (OTC:AWHL) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO